Appropriate Sequence for Afatinib and Cisplatin Combination Improves Anticancer Activity in Head and Neck Squamous Cell Carcinoma

about

Appropriate Sequence for Afatinib and Cisplatin Combination Improves Anticancer Activity in Head and Neck Squamous Cell Carcinoma

Item

http://www.wikidata.org/entity/Q57818008

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Appropriate Sequence for Afati ...... d Neck Squamous Cell Carcinoma

@en

Appropriate Sequence for Afati ...... d Neck Squamous Cell Carcinoma

@nl

type

Item

label

Appropriate Sequence for Afati ...... d Neck Squamous Cell Carcinoma

@en

Appropriate Sequence for Afati ...... d Neck Squamous Cell Carcinoma

@nl

prefLabel

Appropriate Sequence for Afati ...... d Neck Squamous Cell Carcinoma

@en

Appropriate Sequence for Afati ...... d Neck Squamous Cell Carcinoma

@nl

P1476

Appropriate Sequence for Afati ...... d Neck Squamous Cell Carcinoma

@en

P2093

Carine Michiels

http://www.w3.org/2001/XMLSchema#string

Eleonore Longton

http://www.w3.org/2001/XMLSchema#string

François Clement

http://www.w3.org/2001/XMLSchema#string

Kathleen Schmit

http://www.w3.org/2001/XMLSchema#string

Maude Fransolet

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activity

BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Cell signaling by receptor tyrosine kinases

Cancer statistics, 2012

Untangling the ErbB signalling network

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.

P304

432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2018.00432

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30345256

http://www.w3.org/2001/XMLSchema#string

P921

head and neck squamous cell carcinoma

cancer research

P932

6182255

http://www.w3.org/2001/XMLSchema#string